Harvard Bioscience Files 2025 Proxy Statement

Ticker: HBIO · Form: DEF 14A · Filed: Apr 21, 2025 · CIK: 1123494

Harvard Bioscience Inc DEF 14A Filing Summary
FieldDetail
CompanyHarvard Bioscience Inc (HBIO)
Form TypeDEF 14A
Filed DateApr 21, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, corporate-governance, executive-compensation

Related Tickers: HBIO

TL;DR

HBIO proxy filed: exec pay, board elections, shareholder votes coming up.

AI Summary

Harvard Bioscience Inc. filed its DEF 14A on April 21, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key information includes the company's fiscal year end (1231) and its standard industrial classification in Laboratory Analytical Instruments (3826).

Why It Matters

This filing provides shareholders with crucial information regarding executive compensation, director elections, and other governance proposals, enabling informed voting decisions.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing detailing corporate governance and executive compensation, not indicating immediate financial distress or significant new risks.

Key Numbers

  • 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

  • HARVARD BIOSCIENCE INC (company) — Filer
  • 0001171843-25-002341 (filing_id) — Accession Number
  • 20250421 (date) — Filing Date
  • 20250602 (date) — Period of Report
  • 3826 (industry_code) — Standard Industrial Classification

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a definitive proxy statement, is used to solicit shareholder votes on important corporate matters such as the election of directors, executive compensation, and other proposals.

When was this DEF 14A filing submitted by Harvard Bioscience Inc.?

The filing was submitted on April 21, 2025.

What is Harvard Bioscience Inc.'s Standard Industrial Classification code?

Harvard Bioscience Inc.'s Standard Industrial Classification code is 3826, which corresponds to Laboratory Analytical Instruments.

What period does this DEF 14A filing cover?

The filing is for the period of report ending June 2, 2025, and pertains to the fiscal year ending December 31, 2024.

Where is Harvard Bioscience Inc. headquartered?

Harvard Bioscience Inc. is headquartered at 84 October Hill Road, Holliston, MA 01746.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 21, 2025 regarding HARVARD BIOSCIENCE INC (HBIO).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.